TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease
Nature communications, 2022-04, Vol.13 (1), p.2133-2133, Article 2133 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-29719-1 ;PMID: 35440548
Full text available